1281. An Evaluation of Tebipenem In Vitro Activity Against a Panel of Pseudomonas aeruginosa Isolates with Efflux, AmpC, and OprD Mutations

por VanScoy, Brian D, Conde, Haley, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2021

1095. Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model

por VanScoy, Brian D, Conde, Haley, Jones, Sean, Critchley, Ian A, Parr, Thomas R, Cotroneo, Nicole, Ambrose, Paul G
Publicado 2021

1304. Characterization of Tebipenem Pivoxil Hydrobromide Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Acute Pyelonephritis (AP) Model

por VanScoy, Brian D, Fikes, Steven, Rubino, Christopher M, Bhavnani, Sujata M, Cotroneo, Nicole S, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2020

1565. Characterization of Tebipenem (SPR859) Pharmacokinetics–Pharmacodynamics (PK-PD) for Efficacy Against Enterobacteriaceae in a One-Compartment In Vitro Infection Model

por VanScoy, Brian D, Onufrak, Nikolas J, Conde, Haley, Caranco, Ana I, Bhavnani, Sujata M, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2019